×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| ASARFI HOSPITAL LIMITED | NA | NA | NA | NA | 268.0 | 26.1 |
| Lotus Eye Hospital And Institu | 137.04 | 5.45 | 135.17 | 0.26 | 264 | 406.0 |
| GENNEX LABORATORIES LTD. | NA | NA | NA | NA | 257 | 15.7 |
ASARFI HOSPITAL LIMITED, with Security Code 543943, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2023 | Mar 2024 |
|---|---|---|
| Sales | 40.3 | 44.1 |
| Expenses | 32.2 | 36.1 |
| Operating Profit | 8.1 | 8.0 |
| OPM % | 20.09% | 18.14% |
| Other Income | 0.9 | 0.8 |
| Interest | 1.3 | 1.4 |
| Depreciation | 4.4 | 4.4 |
| Profit before tax | 3.3 | 3.0 |
| Tax % | -36.4% | -29.5% |
| Net Profit | 2.1 | 2.1 |
| EPS in Rs | 1.73 | 0.6 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 23% |
| 3 Years: | 23% |
| TTM: | 49% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 33% |
| 3 Years: | 24% |
| TTM: | 161% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 66% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 49% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 154% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 66% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|